NRC National Research Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: NRC

Price (delayed)

$40.35

Market cap

$999.35M

P/E Ratio

28.22

Dividend/share

$0.84

EPS

$1.43

Enterprise value

$990.81M

NRC Health is the leading provider of in-depth customer insights in healthcare.

Highlights
The stock's price to earnings (P/E) is 30% less than its 5-year quarterly average of 40.5
National Research's debt has decreased by 15% YoY and by 4.2% QoQ
The quick ratio has declined by 27% year-on-year and by 24% since the previous quarter
National Research's equity has decreased by 16% QoQ and by 10% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://nrchealth.com
Peers: NWBO

Key stats

What are the main financial stats of NRC
Market
Shares outstanding
24.77M
Market cap
$999.35M
Enterprise value
$990.81M
Valuations
Price to earnings (P/E)
28.22
Price to book (P/B)
14.81
Price to sales (P/S)
6.67
EV/EBIT
20.2
EV/EBITDA
18.21
EV/Sales
6.53
Earnings
Revenue
$151.8M
EBIT
$49.06M
EBITDA
$54.42M
Free cash flow
$32.29M
Per share
EPS
$1.43
Free cash flow per share
$1.29
Book value per share
$2.72
Revenue per share
$6.05
TBVPS
$2.91
Balance sheet
Total assets
$136.23M
Total liabilities
$67.61M
Debt
$24.43M
Equity
$68.62M
Working capital
$12.19M
Liquidity
Debt to equity
0.36
Current ratio
1.31
Quick ratio
1.16
Net debt/EBITDA
-0.16
Margins
EBITDA margin
35.9%
Gross margin
62.8%
Net margin
23.8%
Operating margin
32.4%
Efficiency
Return on assets
24%
Return on equity
45.4%
Return on invested capital
185.5%
Return on capital employed
50.8%
Return on sales
32.3%
Dividend
Dividend yield
2.08%
DPS
$0.84
Payout ratio
58.7%

NRC stock price

How has the National Research stock price performed over time
Intraday
-0.76%
1 week
4.13%
1 month
17.91%
1 year
-6.55%
YTD
-2.82%
QTD
5.41%

Financial performance

How have National Research's revenue and profit performed over time
Revenue
$151.8M
Gross profit
$95.39M
Operating income
$49.21M
Net income
$36.15M
Gross margin
62.8%
Net margin
23.8%
National Research's revenue has increased by 8% YoY
National Research's net margin has decreased by 7% YoY and by 2.5% QoQ
NRC's operating income is up by 6% YoY
NRC's gross profit is up by 5% year-on-year

Growth

What is National Research's growth rate over time

Valuation

What is National Research stock price valuation
P/E
28.22
P/B
14.81
P/S
6.67
EV/EBIT
20.2
EV/EBITDA
18.21
EV/Sales
6.53
The stock's price to earnings (P/E) is 30% less than its 5-year quarterly average of 40.5
NRC's price to book (P/B) is 45% less than its 5-year quarterly average of 27.0 but 15% more than its last 4 quarters average of 12.9
National Research's equity has decreased by 16% QoQ and by 10% YoY
The P/S is 28% lower than the 5-year quarterly average of 9.2 and 3.3% lower than the last 4 quarters average of 6.9
National Research's revenue has increased by 8% YoY

Efficiency

How efficient is National Research business performance
NRC's return on invested capital is up by 44% year-on-year
NRC's return on equity is down by 15% year-on-year
The return on assets has declined by 7% year-on-year
The return on sales has declined by 3.3% year-on-year and by 2.4% since the previous quarter

Dividends

What is NRC's dividend history
DPS
$0.84
Dividend yield
2.08%
Payout ratio
58.7%
Recent dividends

Financial health

How did National Research financials performed over time
NRC's total assets is 102% greater than its total liabilities
The quick ratio has declined by 27% year-on-year and by 24% since the previous quarter
NRC's current ratio is down by 22% YoY and by 21% QoQ
National Research's debt is 64% lower than its equity
NRC's debt to equity is up by 16% QoQ but it is down by 2.7% YoY
National Research's equity has decreased by 16% QoQ and by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.